# Zimmer Biomet Holdings, Inc. – Consensus ‘hold’ rating and 35.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/zimmer-biomet-holdings-inc.consensus-hold-rating-and-35.7-upside-potential/4121132328
- Published: 2023-11-09T13:49:45+00:00
- Author: Charlotte Edwards

**Zimmer Biomet Holdings, Inc.** with ticker code (ZBH) have now 23 analysts in 
total covering the stock. The consensus rating is pointing to ‘hold’. The range 
between the high target price and low target price is between $172.00 and $100.00
with the average target price sitting at $143.78. Given that the stocks previous
close was at $105.93 this indicates there is a potential upside of 35.7%. There 
is a 50 day moving average of $111.95 while the 200 day moving average is $126.62.
The total market capitalization for the company now stands at 21.91B. The stock 
price is currently at: $104.86 USD

 The potential market cap would be $29,743,779,942 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 46.4, revenue per share of $34.79
and a 4.24% return on assets.

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments
include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and 
markets orthopedic reconstructive products; sports medicine, biologics, extremities
and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical 
products; and a suite of integrated digital and robotic technologies that leverage
data, data analytics and artificial intelligence. Its other product category primarily
includes its robotic, surgical and bone cement products. Its products and solutions
help treat patients suffering from disorders of, or injuries to, bones, joints or
supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants,
Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip 
System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular 
System. Its S.E.T. product category includes sports medicine, biologics, foot and
others.

Share on: